A study on efficacy of Ardraka Arka along with standard care in the management of Bronchial Asthma(Tamaka shwasa)
- Conditions
- Health Condition 1: J452- Mild intermittent asthmaHealth Condition 2: J453- Mild persistent asthmaHealth Condition 3: J453- Mild persistent asthma
- Registration Number
- CTRI/2023/08/056522
- Lead Sponsor
- DrPuja MS
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1. Subjects who are known cases of Bronchial Asthma /Tamaka Shwasa and
are already on the treatment of modern medications.
2. Subjects of age group 6-15 years irrespective of gender, religion, caste and
socio-economic status.
3. Subjects having clinical symptoms of Tamaka Shwasa/ Bronchial Asthma:
4. Subjects falling under the mild persistent, mild intermittent and moderate
persistent types of bronchial asthma as per Nelson.
1.Subjects admitted to the hospital due to Asthma exacerbation within 4
weeks prior to the visit.
2.Any known uncontrolled systemic disease.
3.Severe persistent type of asthma will be excluded.
4.Patients with a history of any other diagnosed lung pathology.
5.Subjects incompatible for Spirometry evaluation.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate and compare the effect of Ardraka Arka as an Add-on therapy <br/ ><br>along with standard care on the subjective parameters of Tamaka ShwasaTimepoint: 84 days
- Secondary Outcome Measures
Name Time Method To evaluate & compare the changes in spirometry values before & after <br/ ><br>treatment of Ardraka Arka along with the Standard care in Tamaka Shwasa.Timepoint: 84 days